Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
disease prevention
Fierce Pharma
Cidara snares BARDA award to boost R&D, production of flu asset
Cidara Therapeutics has secured federal backing to develop and produce its experimental flu preventive, dubbed CD388, in the U.S.
Fraiser Kansteiner
Oct 3, 2025 10:10am
Corsera launches with $50M for predictive AI tool, RNAi asset
Sep 2, 2025 6:30am
AstraZeneca shows durability of its COVID-preventing antibodies
Nov 18, 2021 6:28am
AstraZeneca closes in on EUA filing for COVID-19 antibody
Sep 30, 2021 9:00am
AstraZeneca COVID-19 antibody fails in post-exposure prevention
Jun 15, 2021 7:55am
As data near, U.K. rethinks AstraZeneca COVID-19 antibody deal
May 12, 2021 8:30am
